Ono Venture Investment is the corporate venture capital arm of Ono Pharmaceutical, focusing on strategic investments in bio-venture and startup companies within the healthcare and pharmaceutical sectors. Their strategy is to accelerate open innovation by accessing drug discovery targets and cutting-edge technologies, particularly in oncology, immunology, and neurology, to generate innovative medicines.
50% of their portfolio is in Healthcare. Their most common stage is seed (50% of deals).
Portfolio
2
Fund Size
$200M
Top Stage
Seed
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
2 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| VViolet Therapeutics | Seed | $10.6M | May 2023 |
 Arbor Biotechnologies Inc | Series B | $215M | Nov 2021 |
Top Co-Investors
Mass General Brigham Ventures1 shared
Ally Bridge Group1 shared
Temasek Holdings1 shared
ArrowMark Partners1 shared
Deep Track Capital1 shared
Illumina Ventures1 shared
Janus Henderson Investors1 shared
Logos Capital1 shared
Ridgeback Capital1 shared
Section 321 shared
Surveyor Capital1 shared
T. Rowe Price1 shared
Tao Capital Partners1 shared
Tekla Capital Management1 shared
Woodline Partners1 shared
Vertex Pharmaceuticals1 shared
ARCH Venture Partners1 shared
Last updated: 21 April 2026